Cansartan-Mepha plus 32/12.5, Tabletten - 28 Tablette(n) Swissmedic Key 61215009 Registration Holder Mepha Pharma AG Name Cansartan-Mepha plus 32/12.5, Tabletten Date of registration 24.01.2011 Original/Generic Generic Introduction of Sequence 05.09.2014 ATC-Classification Candesartan and Diuretics (C09DA06) Revision date WHO WHO-DDD Valid until Index Therapeuticus (BSV) 02.07.20. Show package size 28 Tablette(n) Index Therapeuticus (Swissmedic) 02.07.20. Description Swissmedic categorie. B SL Eintrag Yes Indication Information for professionals IP Consumer information CI Ex-factory-Price 9.84 Limitation No Deductible 10 % Consumer price 27.15 Feedback FB GTIN 7680612150091 Medication Code Synthetika Pharmacode 6134167 Disponibility
Composition candesartanum cilexetilum 32.00 mg, hydrochlorothiazidum 12.50 mg, maydis amylum, lactosum monohydricum 231.10 mg, triethylis citras, hydroxypropylcellulosum, carmellosum natricum conexum corresp. natrium 0.86 mg, magnesii stearas, pro compresso. Packungsbestandteile Galenic Form Tablets Active Agent Dose Candesartanum Cilexetil 32 mg Hydrochlorothiazide 12.5 mg
BAG: Active Agent Dose Candesartanum Cilexetil 32 mg Hydrochlorothiazide 12.5 mg
Inactive agents Dose Carmellosum Natricum Conexum Hydroxypropylcellulosum Lactose Monohydrate 231.1 mg Magnesii Stearas Maydis Amylum Pro Compresso Triethylis Citras
Source Data was imported : 12.05.2021
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
